Downstream Processing Market

Market Overview

The Global Downstream Processing Market size is expected to be worth around USD 153.8 billion by 2033, from USD 36.1 billion in 2023, growing at a CAGR of 15.6% during the forecast period from 2024 to 2033.

Downstream processing refers to the recovery, purification, and concentration of biosynthetic products, particularly pharmaceuticals, from natural sources such as animal or plant tissue, fermentation broth, or cell cultures. It involves all unit operations after the completion of cell growth and expansion, or drug substance synthesis, to isolate the desired product from the complex bulk matrix.

This process is crucial in biopharmaceutical production, as it ensures the production of a purified final product in large scales, suitable for specific uses. Downstream processing typically includes stages such as cell disruption, separation, filtration, chromatography, ion-exchange, purification, extraction, and clarification.

Key Takeaways

• Market Size: The market is valued at USD 36.1 billion.
• Projected Market Size: It is expected to reach approximately USD 153.8 billion.
• Compound Annual Growth Rate: The market is anticipated to grow at a CAGR of 15.6% from 2023 to 2033.
• Chromatography Systems Market: Chromatography Systems segment holds over 39% of the market in 2023.
• Purification by Chromatography’s Market Share: Dominates with over 38.9% in 2023.
• Antibiotic Production Market Share: Leads with more than 33.6% in 2023.
• North America Dominance: North America is dominating the Downstream Processing Market with a 35.5% share, amounting to USD 12.8 billion in 2023.

Product Type Analysis

In 2023, the Downstream Processing market showcased a diverse array of product types, each contributing significantly to the industry’s dynamics. The segmentation of the market, focusing on Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers, and other product types, reveals varied growth patterns and market share distributions.

• Chromatography Systems: Chromatography held a dominant market position in 2023, capturing more than a 39% share. This segment’s growth can be attributed to its widespread application in pharmaceutical and biotechnological processes, particularly in protein purification. Its precision and efficiency in separating complex mixtures have been key drivers in its adoption.
• Filters: Filters, essential in purifying and separating products, accounted for a significant market share. The demand for high-purity products in the biopharmaceutical industry has spurred the development of advanced filtration technologies. The segment’s growth is bolstered by the need for efficient, scalable solutions in large-scale production environments.
• Evaporators: The evaporator segment, though smaller in comparison, has shown steady growth. Used predominantly in the concentration of liquid solutions, evaporators are vital in reducing processing volumes and improving the efficiency of downstream processes. The adoption of evaporators is driven by their ability to handle a range of viscosities and sensitivities in biological products.
• Centrifuges: Centrifuges play a crucial role in the separation and purification stages of downstream processing. Their market share reflects their indispensability in handling cell cultures and particulates. The advancements in centrifugation technology, aiming at higher throughput and better separation efficiency, have contributed to this segment’s steady growth.
• Dryers: The dryer segment, integral in the final stages of product processing, involves reducing moisture content to stabilize products. This segment’s market presence is underscored by the increasing demand for dry formulations in pharmaceuticals and biotechnology products. Innovations in drying technology, focusing on energy efficiency and product quality, are key growth factors.
• Other Product Types: This category includes a variety of specialized equipment and technologies that cater to niche applications in downstream processing. The diversity within this segment allows it to serve specific requirements that are not entirely met by the other product types, contributing to its steady market presence.

Each segment, characterized by its unique contribution to the downstream processing market, reflects the industry’s evolving landscape. The market’s overall growth is influenced by technological advancements, increasing demand for biopharmaceuticals, and the need for efficient, scalable production methods.

Technique Analysis

The Downstream Processing market, divided into techniques like Cell Disruption, Solid-liquid separation, Filtration, Centrifugation, Concentration, Evaporation, Membrane filtration, Purification by Chromatography, and Formulation, displayed notable trends and market shares.

• Purification by Chromatography: In 2023, purification by chromatography held a dominant market position, capturing more than a 38.9% share. This dominance can be attributed to its widespread application in biopharmaceuticals for protein purification and quality control. The method’s precision in separating complex mixtures enhances its appeal in high-purity applications.
• Cell Disruption: Cell disruption techniques, vital in biotechnology and pharmaceuticals, also command significant market interest. The technique’s efficiency in releasing cellular contents is crucial for downstream processing in bioproducts manufacturing. It serves as a foundational step, impacting the yield and quality of the final product.
• Solid-Liquid Separation: Solid-liquid separation, a fundamental phase in downstream processing, plays a pivotal role in the initial clearing of products. Its utility in separating cellular components from culture media underpins its market importance, impacting subsequent processing steps like filtration and concentration.
• Filtration: Filtration, with its diverse applications in particle removal and clarification, is essential in ensuring product purity. The segment’s growth is driven by the need for high-quality standards in pharmaceuticals, especially in the production of injectable drugs.
• Centrifugation: Centrifugation, a key technique for particle separation based on density, sees substantial use in bioprocessing. Its ability to efficiently separate cells and precipitates from solutions makes it indispensable in many downstream processing operations.
• Concentration: Concentration techniques, crucial in reducing volume and increasing component density, are integral in pharmaceutical and biotechnology processes. This segment’s growth is fueled by the increasing demand for concentrated bioproducts, which require less storage space and have longer shelf lives.
• Evaporation: Evaporation, used to remove solvents and concentrate solutions, is essential in the production of bulk drugs and fine chemicals. Its market significance is underpinned by its role in achieving desired concentration levels in various pharmaceutical products.
• Membrane Filtration: Membrane filtration, an advanced technique for size-based separation, is gaining traction. Its precision in separating molecules based on size makes it a preferred method in the purification of pharmaceuticals, especially in the production of sterile formulations.

Companies are pursuing business development strategies such as acquisitions, mergers, and agreements to expand their chromatography portfolio. Single-use chromatography is and will always be the best in downstream bioprocessing. Repligen, a New Jersey-based company, purchased Newton, New Jersey-based BioFlex solutions in 2021. Repligen’s single-use fluid management product line is enhanced and simplified by the purchase. BioFlex Solutions is integrated into Repligen’s system, further strengthening its offering through the integration of components and assemblies.

Aldevron was acquired by Danaher Corp. in 2021. Aldevron will be an operational business within Danaher’s Life Sciences section. The segment of solid-liquid separation is expected to see the greatest CAGR over the forecast period. Solid-liquid separation has many advantages, including its simplicity, cost-effectiveness, and suitability for continuous-mode production. This technique can be hindered by the high shear forces. For high cell density processes, new developments such as depth filters, multistage depth filters, alternating tangential microfiltration, and tangential flow filtration are being used.

Application Analysis

The Downstream Processing market, categorized by applications such as Antibiotic Production, Hormone Production, Antibodies Production, Enzyme Production, and Vaccine Production, exhibited distinct market shares and growth trajectories.

• Antibiotic Production: In 2023, antibiotic production held a dominant market position, capturing more than a 33.6% share. This segment’s strength is driven by the rising global demand for antibiotics due to increasing incidences of infectious diseases. The efficiency of downstream processing in antibiotic manufacturing plays a crucial role in meeting this demand, underscoring the segment’s market dominance.
• Hormone Production: Hormone production, another key segment, benefits significantly from advancements in downstream processing. The precise extraction and purification processes are vital for the quality and efficacy of hormone therapies. The growing prevalence of hormonal disorders fuels the demand in this market segment.
• Antibodies Production: Antibodies production, integral to the biopharmaceutical industry, also sees substantial market share. The need for high-purity antibodies for therapeutic and diagnostic applications makes downstream processing essential. This segment’s growth is propelled by the increasing use of antibody-based treatments in various diseases.
• Enzyme Production: Enzyme production, critical for numerous industrial applications, relies heavily on downstream processing for product refinement. The sector’s expansion is linked to the broad application of enzymes in sectors like biofuels, food and beverage, and detergents. Efficient downstream processing ensures the high purity and activity levels required in these industries.
• Vaccine Production: Vaccine production, especially relevant in the context of ongoing global health challenges, utilizes downstream processing for the purification and formulation of vaccines. The segment’s growth is driven by the urgent need for vaccines, highlighting the importance of effective downstream processing techniques in ensuring vaccine safety and efficacy.

The wide range of antibiotics that can be used to treat multiple disorders is responsible for this high growth. Annually, more than 700,000 people are affected by antibiotic-resistant bacteria. This results in a high demand for antibiotics which drives the market growth.

The rise in demand for monoclonal antibodies drove the fastest growth in antibody production. The segment growth is also driven by the launch of new products that allow for efficient purification. Cytiva, for example, launched HiScreen Fibro Prisma in 2021 to enable the development and purification of monoclonal antibody (mAb) processes. This product is a fiber-based Protein A platform that allows for a 20-fold increase in productivity.

Кеу Маrkеt Ѕеgmеntѕ

By Product Type

• Chromatography Systems
• Filters
• Evaporators
• Centrifuges
• Dryers
• Other Product Types

By Application

• Antibiotic Production
• Hormone Production
• Antibodies Production
• Enzyme Production
• Vaccine Production

By Technique

• Cell Disruption
• Solid-liquid separation
• Filtration
• Centrifugation
• Concentration
• Evaporation
• Membrane filtration
• Purification by Chromatography
• Formulation

Drivers

• Growth in Biologics and Technological Advances: In 2022, Bayer’s prospective deal with Ginkgo Bioworks emphasized strengthening leadership in biologics through key technology acquisitions. Continuous R&D, like the development of continuous downstream processing systems, is driving market growth. These advancements enable efficient multicomponent separations and perfusion chromatography systems.
• Increased R&D Expenditure: The biopharmaceutical sector is witnessing a surge in R&D spending. For example, in 2020, the pharmaceutical industry globally spent about USD 200 billion on R&D, compared to USD 83 million in 2019. This investment is fueling the adoption of innovative bioprocess technologies.
• Rising Demand for Biopharmaceuticals: The global need for biopharmaceutical products, including monoclonal antibodies and vaccines, is increasing, bolstering the demand for efficient downstream processing.

Restraints

• High Costs: The significant expense of separation and purification processes, often comprising over half the total process cost, is a major constraint. This includes the costs of extensive equipment and steps required to achieve the necessary purity levels.
• Complexity in Bioprocess Monitoring and Control: Advancements in production processes have increased the complexity of bioprocess monitoring and control, especially in biopharmaceutical and nutraceutical industries, presenting challenges in maintaining effective process flow.

Opportunities

• Increased CMO Utilization: Many biopharmaceutical companies are outsourcing manufacturing and downstream processing to specialized Contract Manufacturing Organizations (CMOs), highlighting a growing trend and market opportunity.
• Technological Innovations: Advances in automation, such as the development of digital twins for monoclonal antibody production and the adoption of continuous processing, present significant opportunities. These advancements help overcome constraints and enhance commercial success.

Challenges

• Purification Bottlenecks: The increased demand for bioprocessing technology improvements to address purification bottlenecks is a challenge. While CMOs are being increasingly utilized for their expertise, the fundamental issue of optimizing downstream processing remains.

Trends

• Dominance of Antibodies Production: The antibodies segment is expected to see significant growth due to the rising demand for monoclonal antibodies and the development of advanced downstream processes. Innovations like continuous processing and semi-continuous downstream processes are gaining traction.
• Rising Antibiotic Resistance: The growing issue of antibiotic resistance is fueling the demand for developing new antibodies and, by extension, advanced downstream processing techniques.
• Focus on Automation: Biopharmaceutical manufacturers are increasingly focusing on effective process control and automation in manufacturing. This shift towards intelligent manufacturing is a key trend in the downstream processing market.

Regional Analysis

In 2023, North America is dominating the Downstream Processing Market with a 35.5% share, amounting to USD 12.8 billion. This is due to the government’s support for bioprocess technologies, growing medical expenditure and the development of healthcare infrastructure. The region has seen significant collaborations with major healthcare companies that invest heavily in R&D for biopharmaceuticals. Key players in the market are also expanding their presence in the region. Thermo Fisher Scientific Inc. announced recently a USD 97 million investment to expand its Richmond, Virginia clinical research facilities.

These facilities, which include laboratory operations acquired from PPD, Inc. in 2021, will address the increasing demand for more consistent, higher-quality laboratory services in biopharma. This will help to accelerate drug development. The fastest-growing market in the Asia Pacific is predicted to be 2023-2032, thanks to increased investments by both developers and consumers within the biotechnology sector. A large population base drives the demand for advanced medical facilities. Players are keen to implement rapid analytical methods that support in-process design and bioprocessing.

China was the dominant market in the Asia Pacific region due to its growing biopharmaceutical sector and high demand for vaccines & medicines. China’s biopharmaceutical sector is one of the most dynamic economic sectors. It is characterized by constant innovation with new biopharmaceutical equipment.

Key Regions and Countries

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Key Players Analysis

Companies are increasingly focused on developing new products for downstream processing. Merck, for example, entered into a partnership in 2022 with the Wuxi National High-Tech Industrial Development Zone administrative management Board. Merck’s Mobius a Single Use production center in China was created to significantly expand its premier Mobius. Sartorius purchased Novasep’s Chromatography Section in 2022. The portfolio includes systems for chromatography that are primarily used for small biomolecules such as peptides and oligonucleotides. It also includes new technologies for biologics’ continuous production.

Маrkеt Кеу Рlауеrѕ

• Sartorius Stedim Biotech S.A
• Merck KGaA
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Repligen
• 3M Company
• Boehringer Ingelheim International GmbH
• Corning Corporation
• Lonza Group Ltd
• Dover Corporation
• Ashai Kasei
• Ferner PLC
• Eppendorf AG
• Other Key Players

Recent Developments

• October 2023: Sartorius Stedim Biotech announced the launch of its new BioPAT Cadence software, which provides a comprehensive suite of tools for process optimization and control.
• September 2023: Merck and Agilent Technologies announced a collaboration to develop new process analytical technologies (PAT) for downstream processing.
• August 2023: Thermo Fisher Scientific announced the launch of its new Chromolith Performance RP, a high-performance reversed-phase chromatography resin for the purification of proteins and peptides.
• July 2023: GE Healthcare announced the launch of its new Äkta XCell 75 chromatography system, which is designed for high-throughput purification of biopharmaceuticals.
• June 2023: Danaher Corporation announced the acquisition of Cytiva, a leading provider of downstream processing technologies.